title: Management of coronary artery disease in a severe haemophilia patient with high titre inhibitor and anaphylaxis.
authors.forename: G F
authors.initials: GF
authors.lastname: Rivolta
authors.forename: C
authors.initials: C
authors.lastname: Di Perna
authors.forename: M
authors.initials: M
authors.lastname: Franchini
authors.forename: L
authors.initials: L
authors.lastname: Ippolito
authors.forename: A R
authors.initials: AR
authors.lastname: Maurizio
authors.forename: A
authors.initials: A
authors.lastname: Rocci
authors.forename: A
authors.initials: A
authors.lastname: Tagliaferri
mesh_terms: D000368:Aged; D017023:Coronary Angiography; D003324:Coronary Artery Disease / Q000150:complications* / Q000628:therapy; D005169:Factor VIII / Q000009:adverse effects*; D015942:Factor VIIa / Q000008:administration & dosage*; D006467:Hemophilia A / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008297:Male; D011300:Preoperative Care; D011994:Recombinant Proteins / Q000008:administration & dosage; D051436:Renal Insufficiency, Chronic / Q000150:complications*; D016896:Treatment Outcome
chemical_list: D011994:Recombinant Proteins; C078147:F8 protein, human; D005169:Factor VIII; C103587:recombinant FVIIa; D015942:Factor VIIa